BoostDM

The Biomedical Genomics laboratory at IRB Barcelona has developed a computational tool that identifies cancer driver mutations for each tumour type.

This and other developments produced by the same lab seek to accelerate cancer research and provide tools to help oncologists choose the best treatment for each patient.

The study has been published in the journal Nature.

Thank you!

We would like to thank all those who contributed to our achievements in 2021.
Metastasis continues to be responsible for 90% of cancer-related
deaths and our commitment to end it is stronger than ever.

DONATE

SUBSCRIBE TO OUR NEWS